Eidos Therapeutics, a BridgeBio company
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 5 trials in this atlas.
- Organization
- In this atlas
Overview
Technical summary
Sponsor class industry. No ROR record matches the name exactly.
Trials at a glance
These figures count only the registry trials in this atlas that name Eidos Therapeutics, a BridgeBio company as a sponsor: 5 trials, 5 as lead sponsor and 0 as collaborator.
Phase and status
| Phase | Recruiting | Not yet recruiting | Active, not recruiting | Completed | All statuses |
|---|---|---|---|---|---|
| Phase 3 | 1 | 1 | 1 | 1 | 4 |
| Phase 4 | 1 | 0 | 0 | 0 | 1 |
| All phases | 2 | 1 | 1 | 1 | 5 |
Start year
| Start year | Trials |
|---|---|
| 2026 | 2 |
| 2025 | 1 |
| 2021 | 1 |
| 2019 | 1 |
Main conditions
Main countries
- United States
- Australia
- Belgium
- Brazil
- Canada
Roles
- Company
- Sponsor
Sector
Industry
The registry's words
Labels as the registry gives them, not rewritten.
- Sponsor name
- Eidos Therapeutics, a BridgeBio company
- Sponsor class
- INDUSTRY
Record details
- Record id
cardio:org-eidos-therapeutics-a-bridgebio-company- Content hash
ca3cc9c7ced8ac38aa8aa0d2311583ded98ff09165d9bff6e1779b00cbcccf01